Equity · Healthcare
ALKS
Alkermes plc · NasdaqGS
The line runs $44 on 10 June through $46.11 on 4 September, on a scale from $40 to $60. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ALKS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $44 on 10 June 2026 through $46.11 on 4 September 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026
ALKS insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
ALKS reported financials
ALKS reported revenue of $1.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $241.7M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
ALKS earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ALKS institutional holders
12 of the 45 institutional funds we track reported a ALKS position for the quarter ended 30 Jun 2026 — a combined $1.2B; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
ALKS fails-to-deliver
On 06 Aug 2026, 3,268 shares of ALKS failed to deliver (about $162K).
Source: SEC fails-to-deliver (CNS) data
Congressional trades in ALKS
The most recent congressional trade disclosed in ALKS is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 30 Jul 2026.
Source: U.S. House of Representatives financial disclosures